Clinical Trial Update: Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG [NA]

View source ↗

Summary

A clinical trial investigating early detection of anthracycline cardiotoxicity risk in lymphoma patients using TEP/CT-FDG imaging, currently listed as active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Lymphoma, Non-Hodgkin, Lymphoma, Hodgkin | NA | Status: ACTIVE_NOT_RECRUITING